Investment firm Raymond James has upgraded its rating on Oscar Health, citing improved valuation metrics and a positive outlook for margin recovery. The move signals growing confidence in the health insurance company's ability to improve profitability despite recent industry challenges.

Oscar Health, a technology-driven health insurance provider, has faced headwinds in recent quarters as rising medical costs and competitive pressures squeezed margins. The upgrade suggests analysts believe the company has made progress in addressing these issues and is positioned for improved financial performance. The firm's assessment likely reflects both near-term improvements and longer-term strategic initiatives.

This analyst upgrade could boost investor sentiment toward Oscar Health shares, which have been volatile amid sector-wide concerns about healthcare inflation and regulatory uncertainty. The rating change highlights how valuation adjustments and margin improvement expectations can drive investment recommendations, particularly for companies operating in the dynamic health insurance market.